Sakshaug S - Search Results

1

Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?

Botteri E, Støer NC, Sakshaug S, Graff-Iversen S, Vangen S, Hofvind S, Ursin G, Weiderpass E. Botteri E, et al. Among authors: sakshaug s. Int J Cancer. 2017 Nov 1;141(9):1763-1770. doi: 10.1002/ijc.30878. Epub 2017 Jul 19. Int J Cancer. 2017. PMID: 28685818

2

Postmenopausal hormone therapy and the risk of breast cancer in Norway.

Román M, Sakshaug S, Graff-Iversen S, Vangen S, Weiderpass E, Ursin G, Hofvind S. Román M, et al. Among authors: sakshaug s. Int J Cancer. 2016 Feb 1;138(3):584-93. doi: 10.1002/ijc.29810. Epub 2015 Sep 3. Int J Cancer. 2016. PMID: 26289549

3

Postmenopausal Hormone Therapy and Breast Cancer Prognostic Characteristics: A Linkage between Nationwide Registries.

Román M, Graff-Iversen S, Weiderpass E, Vangen S, Sakshaug S, Hofvind S, Ursin G. Román M, et al. Among authors: sakshaug s. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1464-1473. doi: 10.1158/1055-9965.EPI-16-0240. Epub 2016 Jul 26. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27461048

4

Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.

Botteri E, Støer NC, Sakshaug S, Graff-Iversen S, Vangen S, Hofvind S, de Lange T, Bagnardi V, Ursin G, Weiderpass E. Botteri E, et al. Among authors: sakshaug s. BMJ Open. 2017 Nov 15;7(11):e017639. doi: 10.1136/bmjopen-2017-017639. BMJ Open. 2017. PMID: 29146641 Free PMC article.

5

Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?

Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S. Hofvind S, et al. Among authors: sakshaug s. Int J Cancer. 2012 Jun 15;130(12):2930-8. doi: 10.1002/ijc.26280. Epub 2011 Sep 22. Int J Cancer. 2012. PMID: 21732346

6

Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women.

Thelle DS, Selmer R, Gjesdal K, Sakshaug S, Jugessur A, Graff-Iversen S, Tverdal A, Nystad W. Thelle DS, et al. Among authors: sakshaug s. Heart. 2013 Dec;99(23):1755-60. doi: 10.1136/heartjnl-2013-303825. Epub 2013 Jun 8. Heart. 2013. PMID: 23749790

7

Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.

Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A. Selmer R, et al. Among authors: sakshaug s. Br J Clin Pharmacol. 2009 Mar;67(3):355-62. doi: 10.1111/j.1365-2125.2008.03360.x. Epub 2008 Dec 10. Br J Clin Pharmacol. 2009. PMID: 19523016 Free PMC article.

8

Use of Statins in Kidney Transplant Recipients in Norway.

Rønning M, Hjellvik V, Sakshaug S, Blix HS, Midtvedt K, Reisæter AV, Holdaas H, Åsberg A. Rønning M, et al. Among authors: sakshaug s. Int J Environ Res Public Health. 2022 Jan 26;19(3):1370. doi: 10.3390/ijerph19031370. Int J Environ Res Public Health. 2022. PMID: 35162389 Free PMC article.

9

Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women.

Hjellvik V, Sakshaug S, Strøm H. Hjellvik V, et al. Among authors: sakshaug s. Clin Epidemiol. 2012;4:213-24. doi: 10.2147/CLEP.S31830. Epub 2012 Aug 20. Clin Epidemiol. 2012. PMID: 22936857 Free PMC article.

10

Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids.

Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel Å, Gustavsen I, Mørland J, Skurtveit S. Sakshaug S, et al. Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):292-298. doi: 10.1111/bcpt.12684. Epub 2016 Dec 6. Basic Clin Pharmacol Toxicol. 2017. PMID: 27717229 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters